Yaman, Emel <br/><br/>
Serum M30 levels are associated with survival in advanced gastric carcinoma patients.  [electronic resource] 

 -  International immunopharmacology  Jul 2010 
 - 719-22 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2010.03.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Apoptosis<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma--diagnosis<br/>Caspases--metabolism<br/>Female<br/>Humans<br/>Keratin-18--metabolism<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Peptide Fragments--metabolism<br/>Predictive Value of Tests<br/>Prognosis<br/>Stomach Neoplasms--diagnosis<br/>Survival Analysis<br/>Tumor Burden